• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G126
Device Problems Failure to Capture (1081); High impedance (1291); Over-Sensing (1438); Pacing Problem (1439); Failure to Convert Rhythm (1540)
Patient Problems Headache (1880); Dizziness (2194); Syncope/Fainting (4411); Asystole (4442); Implant Pain (4561)
Event Date 12/04/2022
Event Type  Injury  
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) system was hospitalized due to dizzy spells and episodes of syncope greater than 8 seconds.An in-hospital follow-up was performed and the device programming was adjusted.Reportedly, noise could not be reproduced.In addition, the right ventricular (rv) lead shows an increased shock impedance within normal range and the x-ray shows a sharp bending of the rv lead that may lead to intermittent noise.The crt-d also recorded loss of capture, pacing inhibition and non-conversion of ventricular arrhythmia.Further review by technical services (ts) was requested.The crt-d system remains in service.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) system was hospitalized due to dizziness and light headedness with headache.The patient experienced episodes of syncope and asystole greater than 12 seconds.An in-hospital follow-up was performed and there are no arrhythmia episodes stored by the device and the right ventricular (rv) lead shows an increased shock impedance within normal range.An x-ray was performed and it shows a sharp bending of the rv lead that may lead to intermittent noise.The crt-d also recorded loss of capture, pacing inhibition and non-conversion of ventricular arrhythmia.It was mentioned that the clinic technician has identified the possible cause, and due to the patient heart condition, physical condition and age, the heart has shifted in the thoracic cavity.Therefore, the rv lead does not have enough slack to cover this position.The issue has been identified as p-wave oversensing on the rv lead and it is reproducible.The device programming was adjusted to resolve the event.Further review by technical services (ts) was performed and it was discussed that the oversensing might be related to myopotential noise as it is reproducible with higher sensitivity and while arm exercising.Further discussion on device programming and recommendations were provided.The patient was reported to be worried and angry due to the situation.The patient received latitude for remote monitoring and no further actions are planned at this time.The crt-d system remains in service.
 
Manufacturer Narrative
Correction: h6 field impact codes was updated.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) system was hospitalized due to dizziness and light headedness with headache.The patient experienced episodes of syncope and asystole greater than 12 seconds.An in-hospital follow-up was performed and there are no arrhythmia episodes stored by the device and the right ventricular (rv) lead shows an increased shock impedance within normal range.An x-ray was performed and it shows a sharp bending of the rv lead that may lead to intermittent noise.The crt-d also recorded loss of capture, pacing inhibition and non-conversion of ventricular arrhythmia.It was mentioned that the clinic technician has identified the possible cause, and due to the patient heart condition, physical condition and age, the heart has shifted in the thoracic cavity.Therefore, the rv lead does not have enough slack to cover this position.The issue has been identified as p-wave oversensing on the rv lead and it is reproducible.The device programming was adjusted to resolve the event.Further review by technical services (ts) was performed and it was discussed that the oversensing might be related to myopotential noise as it is reproducible with higher sensitivity and while arm exercising.Further discussion on device programming and recommendations were provided.The patient was reported to be worried and angry due to the situation.The patient received latitude for remote monitoring and no further actions are planned at this time.The crt-d system remains in service.
 
Manufacturer Narrative
Correction: h6 field impact codes was updated.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) system was hospitalized due to dizziness and light headedness with headache.The patient experienced episodes of syncope and asystole greater than 12 seconds.An in-hospital follow-up was performed and there are no arrhythmia episodes stored by the device and the right ventricular (rv) lead shows an increased shock impedance within normal range.An x-ray was performed and it shows a sharp bending of the rv lead that may lead to intermittent noise.The crt-d also recorded loss of capture, pacing inhibition and non-conversion of ventricular arrhythmia.It was mentioned that the clinic technician has identified the possible cause, and due to the patient heart condition, physical condition and age, the heart has shifted in the thoracic cavity.Therefore, the rv lead does not have enough slack to cover this position.The issue has been identified as p-wave oversensing on the rv lead and it is reproducible.The device programming was adjusted to resolve the event.Further review by technical services (ts) was performed and it was discussed that the oversensing might be related to myopotential noise as it is reproducible with higher sensitivity and while arm exercising.Further discussion on device programming and recommendations were provided.The patient was reported to be worried and angry due to the situation.The patient received latitude for remote monitoring and no further actions are planned at this time.The crt-d system remains in service.Additional information provided indicates the patient stated the crt-d device was explanted and replaced and the explanted device is being kept at the patient home.Boston scientific has made three attempts to obtain further information regarding this event, however; no response was received.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) system was hospitalized due to dizziness and light headedness with headache.The patient experienced episodes of syncope and asystole greater than 12 seconds.An in-hospital follow-up was performed and there are no arrhythmia episodes stored by the device and the right ventricular (rv) lead shows an increased shock impedance within normal range.An x-ray was performed and it shows a sharp bending of the rv lead that may lead to intermittent noise.The crt-d also recorded loss of capture, pacing inhibition and non-conversion of ventricular arrhythmia.It was mentioned that the clinic technician has identified the possible cause, and due to the patient heart condition, physical condition and age, the heart has shifted in the thoracic cavity.Therefore, the rv lead does not have enough slack to cover this position.The issue has been identified as p-wave oversensing on the rv lead and it is reproducible.The device programming was adjusted to resolve the event.Further review by technical services (ts) was performed and it was discussed that the oversensing might be related to myopotential noise as it is reproducible with higher sensitivity and while arm exercising.Further discussion on device programming and recommendations were provided.The patient was reported to be worried and angry due to the situation.The patient received latitude for remote monitoring and no further actions are planned at this time.The crt-d system remains in service.Additional information provided indicates the patient stated the crt-d device was explanted and replaced and the explanted device is being kept at the patient home.Reportedly, the device was explanted due to physician discretion as the patient did not trust the device anymore even though there is no medical reason for that.The patient also complained about pain in the pocket area.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15971860
MDR Text Key305386362
Report Number2124215-2022-52461
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589140
UDI-Public00802526589140
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 04/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/02/2020
Device Model NumberG126
Device Catalogue NumberG126
Device Lot Number103048
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/05/2022
Initial Date FDA Received12/13/2022
Supplement Dates Manufacturer Received12/29/2022
01/12/2023
03/08/2023
03/31/2023
Supplement Dates FDA Received01/05/2023
01/12/2023
03/29/2023
04/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/21/2018
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization; Required Intervention;
Patient Age84 YR
Patient SexMale
-
-